SCHEMBL34464730

SCHEMBL34464730

CCCCCC(Br)CC(CC)CCCC

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
TDP1 Q9NUW8 2/20 0.46
CYP3A4 P08684 5/20 0.45
TSHR P16473 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 1/20 0.41
ATM Q13315 1/20 0.39
CA2 P00918 3/20 0.38
LCK P06239 1/20 0.36
PPARD Q03181 1/20 0.36
ZDHHC20 Q5W0Z9 1/20 0.36
ZDHHC2 Q9UIJ5 1/20 0.36
DNM1 Q05193 2/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
OPRM1 P35372 1/20 0.34
ZDHHC7 Q9NXF8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4272611 0.84 ALDH1A1 (0.56) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL25311662 0.82 ALDH1A1 (0.44) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL4271566 0.81 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL4270142 0.81 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL4270730 0.81 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL4269746 0.81 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL758110 0.81 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL4269442 0.81 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL4277904 0.81 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1
SCHEMBL10361006 0.81 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109796-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2026-04-23 US disclosed
US-20260110920-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2026-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260110920-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES ERCC1, ERCC5, ERCC4 ALDH1A1 3021/4885TDP1 2953/4885CYP3A4 476/4885
US-20260109796-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES ERCC1, PDE6H, HCK ALDH1A1 2416/4885TDP1 3645/4885CYP3A4 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.